ROLE OF PRENATAL ULTRASONOGRAPHY IN WOMEN WITH POSITIVE SCREEN FOR DOWN-SYNDROME ON THE BASIS OF MATERNAL SERUM MARKERS

被引:71
|
作者
NYBERG, DA
LUTHY, DA
CHENG, EY
SHELEY, RC
RESTA, RG
WILLIAMS, MA
机构
[1] UNIV WASHINGTON,DEPT OBSTET & GYNECOL,SEATTLE,WA 98195
[2] SWEDISH MED CTR,MED CTR,CTR PERINATAL STUDIES,SEATTLE,WA
关键词
FETUS; CHROMOSOME ABNORMALITIES; PRENATAL ULTRASONOGRAPHY; PRENATAL DIAGNOSIS; DOWN SYNDROME; ALPHA-FETOPROTEIN; TRIPLE SCREEN;
D O I
10.1016/0002-9378(95)91322-X
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: Our purpose was to evaluate the usefulness of prenatal ultrasonography among women with a positive screen for fetal Down syndrome on the basis of three biochemical markers - maternal serum ol-fetoprotein, human chorionic gonadotropin, and unconjugated estriol. STUDY DESIGN: A total of 395 women underwent prenatal ultrasonography at a single institution after being identified as screen positive (midtrimester risk greater than or equal to 1:195) on the basis of triple-marker screening between 15 and 18 weeks. Ultrasonographic findings were compared with the biochemical markers and the eventual fetal outcome for these patients. Ultrasonographic abnormalities that were evaluated included structural defects, nuchal thickening or cystic hygroma, echogenic bowel, cerebral ventricular dilatation, pylectasis, and shortened femur. RESULTS: Among 395 patients, 374 (94.7%) had normal karyotype by genetic amniocentesis (n = 232) or postnatal follow-up (n = 142), 18 (4.5%) proved to have Down syndrome, and three had other karyotypic abnormalities. One or more ultrasonographic abnormalities were found in nine of 18 (50%) with Down syndrome compared to 27 of 377 (7.2%) other fetuses (p < 0.001). Fetuses with abnormal ultrasonography results included three with other chromosome abnormalities and five with nonchromosomal anomalies. An abnormal ultrasonography result increased the risk of Down syndrome by 5.6-fold (25% from 4.5%) and a negative result reduced the risk by 45% (2.5% from 4.5%). The value of ultrasonography is further enhanced when all chromosome abnormalities and nonchromosomal anomalies are considered. CONCLUSION: Abnormal ultrasonographic findings increase the risk for Down syndrome, whereas normal findings are less predictive of normalcy. After correction for inaccurate menstrual dates, genetic amniocentesis should be offered in spite of a normal ultrasonography result among women with positive triple screen.
引用
收藏
页码:1030 / 1035
页数:6
相关论文
共 50 条
  • [41] Genetic counseling, prenatal screening and diagnosis of Down syndrome in the second trimester in women of advanced maternal age: a prospective study
    Qi Qing-wei
    Jiang Yu-lin
    Zhou Xi-ya
    Liu Jun-tao
    Yin Jie
    Bian Xu-ming
    CHINESE MEDICAL JOURNAL, 2013, 126 (11) : 2007 - 2010
  • [42] Repeat testing in antenatal screening for Down syndrome using dimeric inhibin-A in combination with other maternal serum markers
    Hackshaw, AK
    Wald, NJ
    PRENATAL DIAGNOSIS, 2001, 21 (01) : 58 - 61
  • [43] Impact of changing the hCG international standard on Down's syndrome screening by maternal serum markers (AxSYM ®Abbott reagents)
    Baron, S.
    Brochet, C.
    Morin, N.
    Bouberima, M.
    Waroux, M.
    Bernard, M.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2008, 23 (03): : 143 - 147
  • [44] Prenatal diagnosis of mosaic ring chromosome 15 with abnormal maternal serum Down syndrome screening and Dandy-Walker malformation
    Tan, Shun-Jen
    Chen, Chi-Huang
    Chen, Chih-Ping
    Chen, Chun-Wen
    Chen, Cheng-Yu
    Hwang, Kwei-Shuai
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2012, 51 (01): : 109 - 111
  • [45] Sequential combined test, second trimester maternal serum markers, and circulating fetal cells to select women for invasive prenatal diagnosis
    Franchi, Paolo Guanciali
    Palka, Chiara
    Morizio, Elisena
    Sabbatinelli, Giulia
    Alfonsi, Melissa
    Fantasia, Donatella
    Sitar, Giammaria
    Benn, Peter
    Calabrese, Giuseppe
    PLOS ONE, 2017, 12 (12):
  • [46] Maternal serum PlGF (placental growth factor) in Chinese women in the first trimester undergoing screening for Down syndrome
    Han, Jin
    Liu, Han
    Xu, Zun-Peng
    Cuckle, Howard
    Sahota, Daljit
    Li, Dong-Zhi
    Liao, Can
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2016, 201 : 166 - 170
  • [47] 2ND TRIMESTER MATERNAL SERUM PREGNANCY SPECIFIC BETA-1 GLYCOPROTEIN (SP-1) LEVELS IN NORMAL AND DOWN-SYNDROME PREGNANCIES
    PETROCIK, E
    WASSMAN, ER
    LEE, JJ
    KELLY, JC
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1990, 37 (01): : 114 - 118
  • [48] Second trimester maternal serum screening using alpha fetoprotein, free beta human chorionic gonadotropin and maternal age specific risk: Result of chromosomal abnormalities detected in screen positive for Down syndrome in an Asian population
    Chao, AS
    Chung, CL
    Wu, CD
    Chang, SD
    Cheng, PJ
    Lin, YT
    Soong, YK
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1999, 78 (05) : 393 - 397
  • [49] Current controversies in prenatal diagnosis 2: for those women screened by NIPT using cell free DNA, maternal serum markers are obsolete
    Yaron, Yuval
    Hyett, Jon
    Langlois, Sylvie
    PRENATAL DIAGNOSIS, 2016, 36 (13) : 1167 - 1171
  • [50] Type III congenital cystic adenomatoid malformation of the lung detected through maternal serum screening positive for Down's syndrome
    Chen, CP
    Chuang, CY
    Chang, YC
    Tzen, CY
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1997, 76 (04) : 378 - 379